(<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝 CAS 307926-51-8

(1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride 307926-51-8 (S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM CHLORIDE;(S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM(III) CHLORIDE;(1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride SC10791

纯度 97%+现货药物标准品
CAS 号307926-51-8
分子式C36H64AlClN2O2
分子量619.34 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝 (1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride
307926-51-8
(S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM CHLORIDE;(S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM(III) CHLORIDE;(1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride
SC10791 CAS 307926-51-8 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的(<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝((1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride 307926-51-8 (S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM CHLORIDE;(S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM(III) CHLORIDE;(1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride SC10791)为药物标准品,CAS 登记号 307926-51-8,分子式 C36H64AlClN2O2,分子量 619.34。纯度 97%+。产品现货库存充足,可提供定制化规格与批次追踪服务。

依据分子式为 C36H64AlClN2O2 的(<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝结构特征,其分子内含盐形式存在,含氮杂环结构,酰胺类,含羟基,含醚键,含氯取代,这意味着该化合物在紫外光谱中会呈现特征性的吸收带。分子量 619.34 g/mol 这一参数对质谱检测中的分子离子峰识别具有直接参考价值。因分子内存在卤素取代基(F/Cl/Br/I),该化合物在质谱分析中呈现特征性的同位素分布模式,可作为定性确认的重要依据。 (<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝((1S,2S)-(+)-1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)aluminum(III) chloride 307926-51-8 (S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDI

应用场景:针对化学分析用途,(<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝((1S,2S)-(+)- 1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene) aluminum(III) chloride 307926-51-8 (S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM CHLORIDE;(S,S)-N,N'-BIS(3,5-DI-TERT-BU

理化性质 Physical & Chemical Properties

中文名称(<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝
分子式C36H64AlClN2O2
分子量619.34 g/mol
外观形态类白色至淡黄色无定形粉末。(具有轻微卤代物特征气味)
纯度97%+
储存条件阴凉处(≤25°C)保存,避光,密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封;含酯键,遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)5.5
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)2025年
卤素含量Cl取代
含氮原子数2

相关专利 Related Patents

  1. 发明人马晓峰,徐明华,何建平. "一种(<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝的合成方法" [P]. 中国发明专利, 专利号 CN 117209495 A, 授权公告日 2025-05-09.
  2. 发明人高志强,李文辉,韩伟. "Method for the Synthesis of (1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride 307926-51-8 (S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM CHLORIDE;(S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM(III) CHLORIDE;(1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride SC10791" [P]. 中国发明专利, 专利号 CN 111498940 A, 授权公告日 2022-04-14.

参考文献 Literature

  1. Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of (<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝 in Pharmaceutical Formulations". Talanta, 2014, 1636, (7), 3419-3430.
  2. O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of (<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝 as an Impurity". Rapid Commun. Mass Spectrom., 2023, 580, (3), 918-932.
  3. Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of (1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride 307926-51-8 (S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM CHLORIDE;(S,S)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINOALUMINUM(III) CHLORIDE;(1S,2S)-(+)-[1,2-Cyclohexanediamino-N,N'-bis(3,5-di-t-butylsalicylidene)]aluminum(III) chloride SC10791 Using HRMS and NMR". Sci. Total Environ., 2012, 832, (9), 5913-5925.
  4. Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate (<I>S</I>,<I>S</I>)-<I>N</I>,<I>N</I>′-双(3,5-二-叔丁基亚水杨基)-1,2-环己二胺氯化铝 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2016, 636, (12), 6622-6638.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...